People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Supreme Pharmaceuticals Inc. | — | Pharmaceuticals | Seed | $2.9M | $14.1M | 2016 |
Michael La Brier at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael La Brier on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Fowler | 1 | 5 |
| DAVID STADNYK | 1 | 3 |
| GEORGE TSAFALAS | 1 | 3 |
| Scott Walters | 1 | 3 |
| Chris Bechtel | 1 | 3 |
| CHUCK RIFICI | 1 | 2 |
| Tatiana Kovaleva | 1 | 2 |
| Navdeep Dhaliwal | 1 | 1 |
| Allan Levien | 1 | 1 |
| Cailin Gehlsen | 1 | 1 |
| Christopher Bechtel | 1 | 1 |
| Peter Herburger | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.